Erythropoietin Completed Phase 3 Trials for Anemia in Incident Dialysis Patients Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02052310Safety and Efficacy Study for Treatment of Anemia in ESRD Newly Initiated Dialysis Patients